IL17A and synovial sarcoma: Interestingly, in the absence of certain evidence of primary SS, the immunohistochemical detection of IL-17/IL-23 would classify these patients as involved in a Th17 reaction and lead to the selection of patients to be referred for subsequent periodic diagnostic screening.